Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Qun Zeng & Herbert Schwarz. (2020) The role of trogocytosis in immune surveillance of Hodgkin lymphoma. OncoImmunology 9:1.
Read now
Read now
Bhushan Dharmadhikari, Meihui Wu, Nur Sharalyn Abdullah, Sakthi Rajendran, Nur Diana Ishak, Emily Nickles, Zulkarnain Harfuddin & Herbert Schwarz. (2016) CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses. OncoImmunology 5:4.
Read now
Read now
Haley L Peters, Ying Yan & Joyce C. Solheim. (2013) APLP2 regulates the expression of MHC class I molecules on irradiated Ewing’s sarcoma cells. OncoImmunology 2:10.
Read now
Read now
Alexander J Muller, William P Malachowski & George C Prendergast. (2005) Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors. Expert Opinion on Therapeutic Targets 9:4, pages 831-849.
Read now
Read now
Articles from other publishers (27)
Harriet Roddy, Tim Meyer & Claire Roddie. (2022) Novel Cellular Therapies for Hepatocellular Carcinoma. Cancers 14:3, pages 504.
Crossref
Crossref
Hyeon Joo Yoo & Biyan Nathanael Harapan. (2021) Chimeric antigen receptor (CAR) immunotherapy: basic principles, current advances, and future prospects in neuro-oncology. Immunologic Research 69:6, pages 471-486.
Crossref
Crossref
Jiao Wu, Yunpeng Wang & Zheng Jiang. (2020) TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer. Journal of Gastrointestinal Cancer 52:1, pages 150-159.
Crossref
Crossref
Erin Morales, Michael Olson, Fiorella Iglesias, Saurabh Dahiya, Tim Luetkens & Djordje Atanackovic. (2020) Role of immunotherapy in Ewing sarcoma. Journal for ImmunoTherapy of Cancer 8:2, pages e000653.
Crossref
Crossref
Hong Sung Kim. (2019) Development of Genetically Modified Tumor Cell Containing Co-stimulatory Molecule. Biomedical Science Letters 25:4, pages 398-406.
Crossref
Crossref
Yu Ling Shen, Yu Gan, Hai Feng Gao, Ying Chao Fan, Qing Wang, Hui Yuan, Yan Fang Song, Jia Dong Wang & Hong Tu. (2017) TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma. Journal of Digestive Diseases 18:7, pages 395-403.
Crossref
Crossref
Todd Bartkowiak & Michael A. Curran. (2015) 4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity. Frontiers in Oncology 5.
Crossref
Crossref
Bianca Altvater, Sareetha Kailayangiri, Nadine Theimann, Martina Ahlmann, Nicole Farwick, Christiane Chen, Sibylle Pscherer, Ilka Neumann, Gabriele Mrachatz, Anna Hansmeier, Jendrik Hardes, Georg Gosheger, Heribert Juergens & Claudia Rossig. (2014) Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals. Cancer Immunology, Immunotherapy 63:10, pages 1047-1060.
Crossref
Crossref
Edmund K. Moon, Liang-Chuan Wang, Douglas V. Dolfi, Caleph B. Wilson, Raghuveer Ranganathan, Jing Sun, Veena Kapoor, John Scholler, Ellen Puré, Michael C. Milone, Carl H. June, James L. Riley, E. John Wherry & Steven M. Albelda. (2014) Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors. Clinical Cancer Research 20:16, pages 4262-4273.
Crossref
Crossref
Joanna Przybyl, Katarzyna Kozak, Hanna Kosela, Slawomir Falkowski, Tomasz Switaj, Iwona Lugowska, Anna Szumera-Cieckiewicz, Konrad Ptaszynski, Beata Grygalewicz, Magdalena Chechlinska, Barbara Pienkowska-Grela, Maria Debiec-Rychter, Janusz A. Siedlecki & Piotr Rutkowski. (2014) Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications. Medical Oncology 31:8.
Crossref
Crossref
Claudia Rossig. (2014) Cellular immunotherapy strategies for Ewing sarcoma. Immunotherapy 6:5, pages 611-621.
Crossref
Crossref
Douglas S. Hawkins, Sarah Leary, Rochelle Bagatell, Melinda Merchant & Isabelle Aerts. 2014. Hematopoietic Cell Transplantation in Children with Cancer. Hematopoietic Cell Transplantation in Children with Cancer
303
349
.
Tomasz Maj, Shuang Wei, Ted Welling & Weiping Zou. (2013) T Cells and Costimulation in Cancer. The Cancer Journal 19:6, pages 473-482.
Crossref
Crossref
Inbal Daniel-Meshulam, Miryam Horovitz-Fried & Cyrille J. Cohen. (2013) Enhanced antitumor activity mediated by human 4-1BB-engineered T cells. International Journal of Cancer, pages n/a-n/a.
Crossref
Crossref
Dagmar Berghuis, Susy J Santos, Hans J Baelde, Antonie HM Taminiau, R Maarten Egeler, Marco W Schilham, Pancras CW Hogendoorn & Arjan C Lankester. (2011)
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8
+
T-lymphocyte infiltration and affect tumour progression
. The Journal of Pathology 223:3, pages 347-357.
Crossref
Crossref
Angela D PardeeAmy K WesaWalter J Storkus. (2009) Integrating costimulatory agonists to optimize immune-based cancer therapies. Immunotherapy 1:2, pages 249-264.
Crossref
Crossref
Crystal L. Mackall, Eunice H. Rhee, Elizabeth J. Read, Hanh M. Khuu, Susan F. Leitman, Donna Bernstein, Merertu Tesso, Lauren M. Long, David Grindler, Margret Merino, William Kopp, Maria Tsokos, Jay A. Berzofsky & Lee J. Helman. (2008) A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas. Clinical Cancer Research 14:15, pages 4850-4858.
Crossref
Crossref
Hua Zhang, Kristen M. Snyder, Megan M. Suhoski, Marcela V. Maus, Veena Kapoor, Carl H. June & Crystal L. Mackall. (2007) 4-1BB Is Superior to CD28 Costimulation for Generating CD8+ Cytotoxic Lymphocytes for Adoptive Immunotherapy. The Journal of Immunology 179:7, pages 4910-4918.
Crossref
Crossref
Nan Zhang, Rebecca E. Sadun, Robyn S. Arias, Meg L. Flanagan, Suzanne M. Sachsman, Yu-Chih Nien, Leslie A. Khawli, Peisheng Hu & Alan L. Epstein. (2007) Targeted and Untargeted CD137L Fusion Proteins for the Immunotherapy of Experimental Solid Tumors. Clinical Cancer Research 13:9, pages 2758-2767.
Crossref
Crossref
Han Xiao, Bo Huang, Ye Yuan, Dong Li, Ling-Fei Han, Yi Liu, Wei Gong, Feng-Hua Wu, Gui-Mei Zhang & Zuo-Hua Feng. (2007)
Soluble PD-1 Facilitates 4-1BBL–Triggered Antitumor Immunity against Murine H22 Hepatocarcinoma
In vivo
. Clinical Cancer Research 13:6, pages 1823-1830.
Crossref
Crossref
Dass S. Vinay & Byoung S. Kwon. 2007. CD137 Pathway: Immunology and Diseases. CD137 Pathway: Immunology and Diseases
1
14
.
Dass S. Vinay, Kiweon Cha & Byoung S. Kwon. (2006) Dual immunoregulatory pathways of 4-1BB signaling. Journal of Molecular Medicine 84:9, pages 726-736.
Crossref
Crossref
Chie Kudo-Saito, James W. Hodge, Heesun Kwak, Seunghee Kim-Schulze, Jeffrey Schlom & Howard L. Kaufman. (2006) 4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines. Vaccine 24:23, pages 4975-4986.
Crossref
Crossref
Masaki Terabe, Chand Khanna, Seuli Bose, Fraia Melchionda, Arnulfo Mendoza, Crystal L. Mackall, Lee J. Helman & Jay A. Berzofsky. (2006) CD1d-Restricted Natural Killer T Cells Can Down-regulate Tumor Immunosurveillance Independent of Interleukin-4 Receptor-Signal Transducer and Activator of Transcription 6 or Transforming Growth Factor-β. Cancer Research 66:7, pages 3869-3875.
Crossref
Crossref
Daniel H. Fowler. (2006) Shared biology of GVHD and GVT effects: Potential methods of separation. Critical Reviews in Oncology/Hematology 57:3, pages 225-244.
Crossref
Crossref
Satoshi Kawaguchi, Takuro Wada, Tomohide Tsukahara, Kazunori Ida, Toshihiko Torigoe, Noriyuki Sato & Toshihiko Yamashita. (2005) A quest for therapeutic antigens in bone and soft tissue sarcoma. Journal of Translational Medicine 3:1.
Crossref
Crossref
Melinda S. Merchant, Xuezhong Yang, Fraia Melchionda, Maria Romero, Ruth Klein, Carol J. Thiele, Maria Tsokos, H. Udo Kontny & Crystal L. Mackall. (2004) Interferon γ Enhances the Effectiveness of Tumor Necrosis Factor-Related Apoptosis–Inducing Ligand Receptor Agonists in a Xenograft Model of Ewing’s Sarcoma. Cancer Research 64:22, pages 8349-8356.
Crossref
Crossref